Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for CVRx, Inc. (CVRX : NSDQ)
 
 • Company Description   
CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN.

Number of Employees: 109

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.25 Daily Weekly Monthly
20 Day Moving Average: 206,710 shares
Shares Outstanding: 20.50 (millions)
Market Capitalization: $107.63 (millions)
Beta:
52 Week High: $29.00
52 Week Low: $4.60
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 7.36% 20.91%
12 Week -39.24% -33.20%
Year To Date -57.07% -49.55%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
9201 WEST BROADWAY AVENUE SUITE 650
-
MINNEAPOLIS,MN 55445
USA
ph: 763-416-2840
fax: 763-416-2841
ir@cvrx.com http://www.cvrx.com
 
 • General Corporate Information   
Officers
Nadim Yared - Chief Executive Officer and President
Jared Oasheim - Chief Financial Officer
Ali Behbahani - Director
John Nehra - Director
Geoff Pardo - Director

Peer Information
CVRx, Inc. (ABMD)
CVRx, Inc. (DMDS)
CVRx, Inc. (CPWY.)
CVRx, Inc. (EQUR)
CVRx, Inc. (ECIA)
CVRx, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 126638105
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/03/22
Share - Related Items
Shares Outstanding: 20.50
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $107.63 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.54 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.14 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.79
Price/Cash Flow: -
Price / Sales: 7.55
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 5.77%
Sales Growth
vs. Year Ago Period: 42.52%
vs. Previous Quarter: 11.43%
ROE
03/31/22 - -148.64
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -33.31
12/31/21 - -44.26
09/30/21 - -
Current Ratio
03/31/22 - 21.57
12/31/21 - 25.58
09/30/21 - 20.42
Quick Ratio
03/31/22 - 20.77
12/31/21 - 24.92
09/30/21 - 20.03
Operating Margin
03/31/22 - -311.83
12/31/21 - -330.45
09/30/21 - -
Net Margin
03/31/22 - -311.83
12/31/21 - -330.45
09/30/21 - -
Pre-Tax Margin
03/31/22 - -311.13
12/31/21 - -329.76
09/30/21 - -
Book Value
03/31/22 - 6.67
12/31/21 - 7.17
09/30/21 - 7.66
Inventory Turnover
03/31/22 - 0.95
12/31/21 - 1.39
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.10
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 9.39
 

Powered by Zacks Investment Research ©